{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:15:36Z","timestamp":1792109736301,"version":"4.4.0"},"reference-count":82,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Dr. Dillon is supported by University of Virginia Cancer Center Support Grant. Dr. Thomas is supported by Wake Forest Cancer Center Support Grant"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Adenoid cystic carcinoma (ACC) is a rare tumor of secretory glands. In this study, recent advances in molecular characterization and in therapeutics are reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A search of articles in PubMed and of abstracts from national meetings was performed regarding ACC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Recent genetic analyses found that recurrent chromosome 6:9 translocations in ACC generate an MYB:NFIB gene fusion resulting in overexpression of the MYB oncoprotein. Several other frequent mutations are recently published that may be relevant for drug development. Several trials of targeted drugs are reviewed. Some agents delay tumor progression, but tumor responses remain rare.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ACCs have a characteristic chromosomal translocation, but also frequently pick up additional mutations. Clinical research is limited by the rarity and slow growth of ACC. Several ongoing trials are testing agents that inhibit fibroblast growth factor receptor signaling or other signaling pathways. Novel treatments based on the recently sequenced tumor genome are under development. \u00a9 2015 The Authors <jats:italic>Head &amp; Neck<\/jats:italic> Published by Wiley Periodicals, Inc. 38: 620\u2013627, 2016<\/jats:p><\/jats:sec>","DOI":"10.1002\/hed.23925","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T07:29:32Z","timestamp":1418110172000},"page":"620-627","source":"Crossref","is-referenced-by-count":252,"title":["Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials"],"prefix":"10.1002","volume":"38","author":[{"given":"Patrick M.","family":"Dillon","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology University of Virginia Charlottesville Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samhita","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology New Jersey Medical School Newark New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Moskaluk","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Virginia Charlottesville Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant J.","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Virginia Charlottesville Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Y.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Wake Forest University Winston\u2010Salem North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjps.2001.3636"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(74)90265-7"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21458"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)80721-4"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1013"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26740"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.5858\/2009-0527-RS.1"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871001)60:7<1589::AID-CNCR2820600729>3.0.CO;2-U"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1986.tb00631.x"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1003"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.5858\/1999-123-0801-TMIIBA"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-013-0426-3"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.06.014"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.95"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20133231"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2011.105"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64408-2"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000078217"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800209"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2003.31"},{"key":"e_1_2_3_22_1","first-page":"280","article-title":"Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB\u20102, FAS and Ki\u201067","volume":"31","author":"Ito FA","year":"2009","journal-title":"Anal Quant Cytol Histol"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<429::AID-PATH495>3.0.CO;2-1"},{"key":"e_1_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0158"},{"key":"e_1_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2643"},{"key":"e_1_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/87.2.306"},{"key":"e_1_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0241"},{"key":"e_1_2_3_28_1","first-page":"80","article-title":"Studies of genomic imbalances and the MYB\u2010NFIB gene fusion in polymorphous low\u2010grade adenocarcinoma of the head and neck","volume":"40","author":"Persson F","year":"2012","journal-title":"Int J Oncol"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.21965"},{"key":"e_1_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0736-OA"},{"key":"e_1_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21381"},{"key":"e_1_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.86"},{"key":"e_1_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0463"},{"key":"e_1_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.15.12515"},{"key":"e_1_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69070"},{"key":"e_1_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.06.019"},{"key":"e_1_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2013.10.001"},{"key":"e_1_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revsto.2014.02.003"},{"key":"e_1_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.01.001"},{"key":"e_1_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00020840-200404000-00013"},{"key":"e_1_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-3019(97)00341-8"},{"key":"e_1_2_3_42_1","article-title":"International collaborative validation of intraneural invasion as a prognostic marker in adenoid cystic carcinoma of the head and neck","author":"Amit M","year":"2014","journal-title":"Head Neck"},{"key":"e_1_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00122-F"},{"key":"e_1_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20684"},{"key":"e_1_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(97)00153-0"},{"key":"e_1_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.2.149"},{"key":"e_1_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00146085"},{"key":"e_1_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199709000-00022"},{"key":"e_1_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2014.46.1.93"},{"key":"e_1_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.10.010"},{"key":"e_1_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.014"},{"key":"e_1_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2011.11.006"},{"key":"e_1_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.08.008"},{"key":"e_1_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(87)90284-7"},{"key":"e_1_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.151.2.6324280"},{"key":"e_1_2_3_56_1","unstructured":"National Comprehensive Cancer Network. Head and neck cancer (version 2.2014).2014. Available at:www.nccn.org. Accessed June 30 2014."},{"key":"e_1_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(84)90007-5"},{"key":"e_1_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)00273-5"},{"key":"e_1_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-1-17"},{"key":"e_1_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.08.013"},{"key":"e_1_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70245-X"},{"key":"e_1_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1981.00790480015004"},{"key":"e_1_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.2880140403"},{"key":"e_1_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911101)68:9<1874::AID-CNCR2820680904>3.0.CO;2-S"},{"key":"e_1_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.02.002"},{"key":"e_1_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.05.635"},{"key":"e_1_2_3_67_1","first-page":"956","article-title":"KIT protein expression and analysis of c\u2010kit gene mutation in adenoid cystic carcinoma","volume":"12","author":"Holst VA","year":"1999","journal-title":"Mod Pathol"},{"key":"e_1_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2010.09.013"},{"key":"e_1_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-008-0101-x"},{"key":"e_1_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.125"},{"key":"e_1_2_3_71_1","article-title":"A phase II study of gefitinib in patients with advanced salivary gland cancers","author":"Jakob JA","year":"2014","journal-title":"Head Neck"},{"key":"e_1_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.07.010"},{"key":"e_1_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.468"},{"key":"e_1_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.8612"},{"key":"e_1_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.4248\/IJOS10005"},{"key":"e_1_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr522"},{"key":"e_1_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.192"},{"key":"e_1_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909114106"},{"key":"e_1_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25852"},{"key":"e_1_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-1947-2"},{"key":"e_1_2_3_81_1","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.6021","article-title":"Phase II study of dovitinib (TKI258) in patients with progressive metastatic adenoid cystic carcinoma","volume":"31","author":"Dillon P","year":"2013","journal-title":"J Clin Oncol"},{"key":"e_1_2_3_82_1","doi-asserted-by":"crossref","first-page":"abstract 6045","DOI":"10.1200\/jco.2013.31.15_suppl.6045","article-title":"A phase II study of suberoylanilide hydroxamic acid (SAHA) in subjects with locally advanced, recurrent, or metastatic adenoid cystic carcinoma (ACC)","volume":"31","author":"Goncalves P","year":"2013","journal-title":"J Clin Oncol"},{"key":"e_1_2_3_83_1","article-title":"Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: results of a phase II clinical trial","author":"Hoover AC","year":"2014","journal-title":"Head Neck"}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.23925","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.23925","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.23925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T03:09:45Z","timestamp":1695006585000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.23925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1002\/hed.23925"],"URL":"https:\/\/doi.org\/10.1002\/hed.23925","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"value":"1043-3074","type":"print"},{"value":"1097-0347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]}}}